Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,614.00
Bid: 1,614.00
Ask: 1,616.00
Change: 10.00 (0.62%)
Spread: 2.00 (0.124%)
Open: 1,602.00
High: 1,616.00
Low: 1,602.00
Prev. Close: 1,604.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Euro Medium Term Note Programme

20 Oct 2017 14:17

RNS Number : 2311U
Smiths Group PLC
20 October 2017
 

 

News Release

London, 20 October 2017

For immediate release

 

 

€2.5bn Euro Medium Term Note Programme

Smiths Group plc (the "Company") announces today that it has updated its €2.5 billion Euro Medium Term Note Programme (the "EMTN programme") with its 10 relationship banks as dealers.

The EMTN programme will continue to facilitate the issuance by the Company of senior notes over time in various currencies and maturities. Notes issued under the EMTN programme will be guaranteed by Smiths Group International Holdings Limited.

Bill Seeger, Chief Financial Officer, said:

"This programme continues to be an essential foundation for our financing strategy having been the vehicle for the €650m 2% 10 year notes issued in February 2017. We aim to finance our balance sheet from the rated public debt markets and the programme provides us with considerable flexibility in both the refinancing of existing debt maturities and to support the strategic development of our business portfolio."

A base prospectus dated 20 October 2017 relating to the update of the EMTN programme (the "Prospectus") has been approved by the UK Listing Authority and is available for viewing.

To view the Prospectus, please paste the following URL into the address bar of your browser: http://www.rns-pdf.londonstockexchange.com/rns/2311U_1-2017-10-20.pdf

The Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do. 

ENDS

 

 

Contact details

 

Investor enquiries

Jemma Spalton, Smiths Group

+44 (0)20 7004 1637

+44 (0)78 6739 0350

jemma.spalton@smiths.com

 

Marion Le Bot, Smiths Group

+44 (0)20 7004 1672

+44 (0)75 8315 4386

marion.lebot@smiths.com

 

Media enquiries

Andrew Lorenz, FTI Consulting

+44 (0)203 727 1323

+44 (0)777 564 1807

smiths@fticonsulting.com

 

Deborah Scott, FTI Consulting

+44 (0)203 727 1459

+44 (0)797 953 7449

smiths@fticonsulting.com

 

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs 22,000 people in over 50 countries. For more information visit www.smiths.com

 

 

Disclaimer - intended addressees

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. Neither the Prospectus nor this announcement is intended for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMMZGFGZGNZM
Date   Source Headline
7th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20227:00 amRNSTransaction in Own Shares
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20222:30 pmRNSDirector Declaration
2nd Mar 20227:00 amRNSTransaction in Own Shares
1st Mar 20229:30 amRNSTotal Voting Rights
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20227:00 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 202210:00 amRNSDirector Responsibilities
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 202211:00 amRNSNotice of Redemption Price
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:30 amRNSShare Buyback Programme
11th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSTransaction in Own Shares
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20222:30 pmRNSDirector/PDMR Shareholding
1st Feb 20222:00 pmRNSDirector Responsibilities
1st Feb 20221:30 pmRNSTotal Voting Rights
1st Feb 20227:00 amRNSTransaction in Own Shares
31st Jan 202212:00 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
27th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:00 amRNSTransaction in Own Shares
25th Jan 20227:00 amRNSTransaction in Own Shares
24th Jan 20227:00 amRNSTransaction in Own Shares
21st Jan 20228:00 amRNSAdditional Listing
21st Jan 20227:00 amRNSTransaction in Own Shares
20th Jan 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSTransaction in Own Shares
18th Jan 20227:00 amRNSTransaction in Own Shares
17th Jan 20227:00 amRNSTransaction in Own Shares
14th Jan 20227:00 amRNSTransaction in Own Shares
13th Jan 202210:10 amRNSNotice of Optional Redemption
13th Jan 20227:00 amRNSTransaction in Own Shares
12th Jan 20227:00 amRNSTransaction in Own Shares
11th Jan 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.